{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:15:58Z","timestamp":1790709358808,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jacc.2025.10.021","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T15:32:30Z","timestamp":1765985550000},"page":"533-545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Delayed Diagnosis of Transthyretin Amyloid Cardiomyopathy in the Veterans Health Administration"],"prefix":"10.1016","volume":"87","author":[{"given":"Gabriela","family":"Spencer-Bonilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anubodh","family":"Varshney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5226-0723","authenticated-orcid":false,"given":"Fatima","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia A.","family":"Papas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Venditto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald M.","family":"Witteles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander T.","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.jacc.2025.10.021_bib1","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC State-of-the-Art Review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2025.10.021_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/13506129.2015.1051219","article-title":"Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African-Americans","volume":"22","author":"Jacobson","year":"2015","journal-title":"Amyloid"},{"issue":"9","key":"10.1016\/j.jacc.2025.10.021_bib3","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/jamacardio.2018.2093","article-title":"Geographic disparities in reported US amyloidosis mortality from 1979 to 2015: potential underdetection of cardiac amyloidosis","volume":"3","author":"Alexander","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.jacc.2025.10.021_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s40119-021-00219-5","article-title":"Impact of delayed diagnosis and misdiagnosis for patients with transthyretin amyloid cardiomyopathy (ATTR-CM): a targeted literature review","volume":"10","author":"Rozenbaum","year":"2021","journal-title":"Cardiol Ther"},{"issue":"8","key":"10.1016\/j.jacc.2025.10.021_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11936-019-0743-2","article-title":"Emerging therapies for transthyretin cardiac amyloidosis","volume":"21","author":"Alexander","year":"2019","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"11","key":"10.1016\/j.jacc.2025.10.021_bib6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jacc.2025.10.021_bib7","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1208760","article-title":"Safety and efficacy of RNAi therapy for transthyretin amyloidosis","volume":"369","author":"Coelho","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.10.021_bib8","doi-asserted-by":"crossref","DOI":"10.1007\/s40615-025-02515-5","article-title":"Health status and delays in referral-to-treatment waiting times for elective admissions of adults from deprived areas and ethnic minority backgrounds: a study of healthcare inequalities","author":"Fluck","year":"2025","journal-title":"J Racial Ethn Health Disparities"},{"issue":"8","key":"10.1016\/j.jacc.2025.10.021_bib9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jchf.2019.04.010","article-title":"Screening for transthyretin amyloid cardiomyopathy in everyday practice","volume":"7","author":"Witteles","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"2","key":"10.1016\/j.jacc.2025.10.021_bib10","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/ehf2.15016","article-title":"Transthyretin amyloid cardiomyopathy: literature review and red-flag symptom clusters for each cardiology specialty","volume":"12","author":"Izumiya","year":"2025","journal-title":"ESC Heart Fail"},{"issue":"8","key":"10.1016\/j.jacc.2025.10.021_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008538","article-title":"Disparity in the setting of incident heart failure diagnosis","volume":"14","author":"Sandhu","year":"2021","journal-title":"Circ Heart Fail"},{"issue":"9","key":"10.1016\/j.jacc.2025.10.021_bib12","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/pds.5066","article-title":"Impact of variable look-back periods on the incidence rates of chronic diseases using real world data","volume":"29","author":"Rosenlund","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"10.1016\/j.jacc.2025.10.021_bib13","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1253\/circj.CJ-22-0032","article-title":"New conversion formula between B-type natriuretic peptide and N-terminal-pro-B-type natriuretic peptide\u2014analysis from a multicenter study","volume":"86","author":"Ishihara","year":"2022","journal-title":"Circ J"},{"issue":"18","key":"10.1016\/j.jacc.2025.10.021_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026308","article-title":"Modeling the cost and health impacts of diagnostic strategies in patients with suspected transthyretin cardiac amyloidosis","volume":"11","author":"Ge","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.jacc.2025.10.021_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s13023-023-02933-w","article-title":"Incidence and survival of transthyretin amyloid cardiomyopathy from a French nationwide study of in- and out-patient databases","volume":"18","author":"Damy","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.jacc.2025.10.021_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13023-020-01623-1","article-title":"The patient journey toward a diagnosis of hereditary transthyretin (ATTRv) amyloidosis","volume":"16","author":"Vera-Llonch","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"14","key":"10.1016\/j.jacc.2025.10.021_bib17","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2217\/cer-2022-0074","article-title":"Clinical manifestations and healthcare utilization before diagnosis of transthyretin amyloidosis","volume":"11","author":"Nativi-Nicolau","year":"2022","journal-title":"J Comp Eff Res"},{"issue":"1","key":"10.1016\/j.jacc.2025.10.021_bib18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13023-022-02425-3","article-title":"Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis","volume":"17","author":"Jang","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.jacc.2025.10.021_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40256-022-00563-4","article-title":"Real-world characteristics of patients with wild-type transthyretin amyloid cardiomyopathy: an analysis of electronic healthcare records in the United States","volume":"23","author":"Bhambri","year":"2023","journal-title":"Am J Cardiovasc Drugs"},{"issue":"1","key":"10.1016\/j.jacc.2025.10.021_bib20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s13023-023-02962-5","article-title":"A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS)","volume":"18","author":"Gentile","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"22","key":"10.1016\/j.jacc.2025.10.021_bib21","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1161\/CIRCULATIONAHA.122.060852","article-title":"Impact of earlier diagnosis in cardiac ATTR amyloidosis over the course of 20 years","volume":"146","author":"Ioannou","year":"2022","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacc.2025.10.021_bib22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/13506129.2018.1498782","article-title":"Seven factors predict a delayed diagnosis of cardiac amyloidosis","volume":"25","author":"Bishop","year":"2018","journal-title":"Amyloid"},{"issue":"21","key":"10.1016\/j.jacc.2025.10.021_bib23","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1001\/jama.2024.2868","article-title":"Addressing health disparities-the case for variant transthyretin cardiac amyloidosis grows stronger","volume":"331","author":"Maurer","year":"2024","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jacc.2025.10.021_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jchf.2022.08.023","article-title":"Treatment differences in medical therapy for heart failure with reduced ejection fraction between sociodemographic groups","volume":"11","author":"Witting","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"6","key":"10.1016\/j.jacc.2025.10.021_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010718","article-title":"Equity in the setting of heart failure diagnosis: an analysis of differences between and within clinician practices","volume":"17","author":"Gupta","year":"2024","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.jacc.2025.10.021_bib26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jchf.2022.11.013","article-title":"Predictors of incident heart failure diagnosis setting: insights from the Veterans Affairs Healthcare System","volume":"11","author":"Tisdale","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.10.021_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2019.07.022","article-title":"Cardiac amyloidosis: an underdiagnosed\/underappreciated disease","volume":"67","author":"Manolis","year":"2019","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.jacc.2025.10.021_bib28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/13506129.2022.2159369","article-title":"Cardiac amyloidosis remains significantly underdiagnosed in patients undergoing TAVR: analysis of national inpatient sample","volume":"30","author":"Terentes-Printzios","year":"2023","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2025.10.021_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychores.2024.111604","article-title":"Serious mental illness is associated with elevated risk of hospital readmission in veterans with heart failure","volume":"178","author":"Browne","year":"2024","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.jacc.2025.10.021_bib30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1472-6963-7-146","article-title":"Severe mental illness and mortality of hospitalized ACS patients in the VHA","volume":"7","author":"Plomondon","year":"2007","journal-title":"BMC Health Serv Res"},{"issue":"24","key":"10.1016\/j.jacc.2025.10.021_bib31","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/eurheartj\/ehx043","article-title":"Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths","volume":"38","author":"Gonzalez-Lopez","year":"2017","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacc.2025.10.021_bib32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/01.CIR.0000078641.19365.4C","article-title":"Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance","volume":"108","author":"McCrohon","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jacc.2025.10.021_bib33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.hlc.2021.12.014","article-title":"Missed opportunities in identifying cardiomyopathy aetiology prior to advanced heart failure therapy","volume":"31","author":"Aiad","year":"2022","journal-title":"Heart Lung Circ"},{"issue":"9","key":"10.1016\/j.jacc.2025.10.021_bib34","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2021.11.061","article-title":"Variability in coronary artery disease testing for patients with new-onset heart failure","volume":"79","author":"Zheng","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jacc.2025.10.021_bib35","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.medcli.2023.06.023","article-title":"Importance of genetic study in elderly patients with transthyretin cardiac amyloidosis","volume":"161","author":"Gallego Delgado","year":"2023","journal-title":"Med Clin (Barc)"},{"issue":"4","key":"10.1016\/j.jacc.2025.10.021_bib36","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ejhf.2776","article-title":"Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy","volume":"25","author":"Porcari","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.jacc.2025.10.021_bib37","first-page":"301","article-title":"Prevalence of transthyretin cardiac amyloidosis in patients with heart failure with preserved ejection fraction: the PRACTICA study","volume":"78","author":"Garcia-Pavia","year":"2025","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"23","key":"10.1016\/j.jacc.2025.10.021_bib38","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033770","article-title":"Hereditary transthyretin amyloidosis in patients referred to a genetic testing program","volume":"13","author":"Bhatt","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.jacc.2025.10.021_bib39","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.ajhg.2025.03.009","article-title":"Characterizing trends in clinical genetic testing: a single-center analysis of EHR data from 1.8 million patients over two decades","volume":"112","author":"Bastarache","year":"2025","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.jacc.2025.10.021_bib40","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725099218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725099218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T21:15:21Z","timestamp":1770844521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109725099218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0735109725099218"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2025.10.021","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delayed Diagnosis of Transthyretin Amyloid Cardiomyopathy in the Veterans Health Administration","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier on behalf of the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}